Bioengineering Cell Therapy for Treatment of Peripheral Artery Disease.
Ngan F HuangBrett SternBeu P OropezaTatiana S ZaitsevaMichael V PaukshtoJanet ZoldanPublished in: Arteriosclerosis, thrombosis, and vascular biology (2024)
Peripheral artery disease is an atherosclerotic disease associated with limb ischemia that necessitates limb amputation in severe cases. Cell therapies comprised of adult mononuclear or stromal cells have been clinically tested and show moderate benefits. Bioengineering strategies can be applied to modify cell behavior and function in a controllable fashion. Using mechanically tunable or spatially controllable biomaterials, we highlight examples in which biomaterials can increase the survival and function of the transplanted cells to improve their revascularization efficacy in preclinical models. Biomaterials can be used in conjunction with soluble factors or genetic approaches to further modulate the behavior of transplanted cells and the locally implanted tissue environment in vivo. We critically assess the advances in bioengineering strategies such as 3-dimensional bioprinting and immunomodulatory biomaterials that can be applied to the treatment of peripheral artery disease and then discuss the current challenges and future directions in the implementation of bioengineering strategies.
Keyphrases
- peripheral artery disease
- induced apoptosis
- cell therapy
- single cell
- tissue engineering
- cell cycle arrest
- healthcare
- primary care
- gene expression
- stem cells
- oxidative stress
- bone regeneration
- signaling pathway
- bone marrow
- percutaneous coronary intervention
- coronary artery disease
- combination therapy
- cell proliferation
- acute coronary syndrome
- cell death
- young adults
- copy number
- atrial fibrillation
- free survival
- drug induced